Supply Chain

Here are the six latest drugs or medical devices approved by the Food and Drug Administration.

"Data is a vital asset for improving today's healthcare supply chain. But not just any data. Healthcare providers need access to information that delivers accurate, insightful comparisons of the multitude of products and manufacturers used in their systems in order…

 The Food and Drug Administration's Center for Devices and Radiological Health released its list of regulatory science priorities for 2017.

BD, a Franklin Lakes, N.J.-based medical technology company, recently unveiled the BD Veritor Plus System, a wireless diagnostic device that can detect influenza A and B, respiratory syncytial virus and group A strep.

Completely autonomous robots may replace warehouse workers in the not so far-off future, thanks to the ingenuity of millionaire Rick Cohen.

Members of Congress grilled Mylan CEO Heather Bresch with questions about the high price of EpiPens during her Wednesday hearing with the House Committee on Oversight and Government Reform, according to The New York Times.

While Mylan's EpiPen price hikes may not be good business, they shouldn't be a federal issue, said athenahealth CEO Jonathan Bush during a Thursday appearance on Fox Business' "Mornings with Maria Bartiromo."

Starting Jan. 2, FedEx will use a costlier price formula to calculate shipping rates for domestic air or ground parcels that's based on the package's dimensions, instead of actual weight, reported DC Velocity.

Lawmakers questioned Janet Woodcock, MD, director of the Center for Drug Evaluation and Research at the Food and Drug Administration, about the agency's efforts to approve new generic drugs during a Senate Appropriations Subcommittee hearing on Wednesday.

The Food and Drug Administration granted tentative approval to AuroBindo Pharma for dolutegravir, a drug intended to treat patients with HIV, reported Business Standard.